A detailed history of Abn Amro Investment Solutions transactions in Dexcom Inc stock. As of the latest transaction made, Abn Amro Investment Solutions holds 35,099 shares of DXCM stock, worth $2.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
35,099
Previous 4,450 688.74%
Holding current value
$2.04 Million
Previous $388 Million 508.02%
% of portfolio
0.05%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$66.46 - $89.53 $2.04 Million - $2.74 Million
30,649 Added 688.74%
35,099 $2.36 Billion
Q2 2025

Aug 08, 2025

BUY
$59.83 - $87.57 $266,243 - $389,686
4,450 New
4,450 $388 Million
Q1 2025

Aug 27, 2025

SELL
$67.74 - $90.75 $29,873 - $40,020
-441 Reduced 9.91%
4,009 $274 Million
Q4 2024

Sep 04, 2025

BUY
$65.68 - $81.01 $154,085 - $190,049
2,346 Added 41.04%
8,062 $627 Million
Q3 2024

Sep 04, 2025

BUY
$64.0 - $116.06 $81,024 - $146,931
1,266 Added 28.45%
5,716 $383 Million
Q2 2024

Sep 04, 2025

BUY
$110.31 - $140.45 $3.34 Million - $4.25 Million
30,284 Added 680.54%
34,734 $3.94 Billion
Q1 2024

Sep 05, 2025

BUY
$114.22 - $140.1 $73,329 - $89,944
642 Added 2.95%
22,415 $3.11 Billion
Q4 2023

Sep 05, 2025

BUY
$75.49 - $124.16 $1,509 - $2,483
20 Added 0.09%
21,773 $2.7 Billion
Q3 2023

Nov 07, 2025

SELL
$86.06 - $137.93 $1.15 Million - $1.84 Million
-13,346 Reduced 38.02%
21,753 $2.03 Billion
Q3 2023

Nov 03, 2025

BUY
$86.06 - $137.93 $2.64 Million - $4.23 Million
30,649 Added 688.74%
35,099 $2.36 Billion
Q3 2023

Sep 05, 2025

BUY
$86.06 - $137.93 $1.12 Million - $1.8 Million
13,032 Added 149.43%
21,753 $2.03 Billion
Q2 2023

Sep 05, 2025

SELL
$112.47 - $130.98 $33,741 - $39,294
-300 Reduced 3.33%
8,721 $1.12 Billion
Q1 2023

Sep 05, 2025

BUY
$104.0 - $122.92 $475,384 - $561,867
4,571 Added 102.72%
9,021 $1.05 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Abn Amro Investment Solutions Portfolio

Follow Abn Amro Investment Solutions and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

News

Stay updated on Abn Amro Investment Solutions with notifications on news.